¹⁸F-FDG and ¹⁸F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis

References

• Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69(6):964–75.
   PubMed Web of Science ®Google Scholar
• van der Heide A, Remme CA, Hofman DM, Jacobs JW, Bijlsma JW. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum. 1995;38(10):1466–74.
   PubMed Web of Science ®Google Scholar
• Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, et al. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology. 2003;42(8):939–46.
   PubMed Web of Science ®Google Scholar
• Meyer O, Nicaise-Roland P, Santos MD, Labarre C, Dougados M, Goupille P, et al. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis. Arthritis Res Ther. 2006;8(2):R40.
   PubMed Web of Science ®Google Scholar
• Korb-Pap A, Stratis A, Mühlenberg K, Niederreiter B, Hayer S, Echtermeyer F, et al. Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis. Ann Rheum Dis. 2012;71(6):1004–11.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492–509.
   PubMed Web of Science ®Google Scholar
• Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum. 2006;55(6):864–72.
   PubMed Web of Science ®Google Scholar
• Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D’Agostino MA, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis. 2013;72(6):804–14.
   PubMed Web of Science ®Google Scholar
• Yoshimi R, Hama M, Takase K, Ihata A, Kishimoto D, Terauchi K, et al. Ultrasonography is a potent tool for the prediction of progressive joint destruction during clinical remission of rheumatoid arthritis. Mod Rheumatol. 2013;23(3):456–65.
   PubMed Web of Science ®Google Scholar
• Danks L, Takayanagi H. Immunology and bone. J Biochem. 2013; 154(1):29–39.
   PubMed Web of Science ®Google Scholar
• Walsh NC, Crotti TN, Goldring SR, Gravallese EM. Rheumatic diseases: the effects of inflammation on bone. Immunol Rev. 2005;208:228–51.
   PubMed Web of Science ®Google Scholar
• Wunder A, Straub RH, Gay S, Funk J, Müller-Ladner U. Molecular imaging: novel tools in visualizing rheumatoid arthritis. Rheumatology. 2005;44(11):1341–9.
   PubMed Web of Science ®Google Scholar
• McQueen FM, Ostergaard M. Established rheumatoid arthritis—new imaging modalities. Best Pract Res Clin Rheumatol. 2007;21(5):841–56.
   PubMed Web of Science ®Google Scholar
• Beckers C, Jeukens X, Ribbens C, André B, Marcelis S, Leclercq P, et al. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging. 2006;33(3):275–80.
   PubMed Web of Science ®Google Scholar
• Vijayant V, Sarma M, Aurangabadkar H, Bichile L, Basu S. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies. World J Radiol. 2012;4(12):462–8.
   PubMedGoogle Scholar
• Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, et al. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology. 2012;51(8):1484–91.
   PubMed Web of Science ®Google Scholar
• Roivainen A, Hautaniemi S, Möttönen T, Nuutila P, Oikonen V, Parkkola R, et al. Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs. Eur J Nucl Med Mol Imaging. 2013;40(3):403–10.
   PubMed Web of Science ®Google Scholar
• Karapolat I, Sertpoyraz F, Oncel G, Kobak S, Yalcin M, Kumanlioglu K. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method? Nuklearmedizin. 2013;52(6): 244–9.
   PubMedGoogle Scholar
• Draper CE, Quon A, Fredericson M, Besier TF, Delp SL, Beaupre GS, et al. Comparison of MRI and 18F-NaF PET/CT in patients with patellofemoral pain. J Magn Reson Imaging. 2012;36(4):928–32.
   PubMed Web of Science ®Google Scholar
• Quon A, Dodd R, Iagaru A, de Abreu MR, Hennemann S, Alves Neto JM, et al. Initial investigation of 18F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery. Eur J Nucl Med Mol Imaging. 2012;39(11):1737–44.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Inaba Y, Tateishi U, Yukizawa Y, Ike H, Inoue T, et al. New application of 18F-fluoride PET for the detection of bone remodeling in early-stage osteoarthritis of the hip. Clin Nucl Med. 2013;38(10):e379–83.
   PubMed Web of Science ®Google Scholar
• Tan AL, Tanner SF, Waller ML, Hensor EM, Burns A, Jeavons AP, et al. High-resolution [18F]fluoride positron emission tomography of the distal interphalangeal joint in psoriatic arthritis–a bone-enthesis-nail complex. Rheumatology. 2013;52(5):898–904.
   PubMed Web of Science ®Google Scholar
• Fogelman I, Blake GM, Cook GJ. The isotope bone scan: we can do better. Eur J Nucl Med Mol Imaging. 2013;40(8):1139–40.
   PubMed Web of Science ®Google Scholar
• Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med. 2010;51(12):1826–9.
   PubMed Web of Science ®Google Scholar
• Irmler IM, Gebhardt P, Hoffmann B, Opfermann T, Figge MT, Saluz HP, et al. 18F-Fluoride positron emission tomography/computed tomography for non-invasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis. Arthritis Res Ther. 2014;16(4):R155.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K, Pincus T. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis and rheumatism. 2004;50(10):3296–305.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–8.
   PubMed Web of Science ®Google Scholar
• Genant HK, Jiang Y, Peterfy C, Lu Y, Redei J, Countryman PJ. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum. 1998;41(9):1583–90.
   PubMed Web of Science ®Google Scholar
• Matsui T, Nakata N, Nagai S, Nakatani A, Takahashi M, Momose T, et al. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med. 2009;50:920–6.
   PubMed Web of Science ®Google Scholar
• Irmler IM, Opfermann T, Gebhardt P, Gajda M, Bräuer R, Saluz HP, et al. In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography. Arthritis Res Ther. 2010;12(6):R203.
   PubMed Web of Science ®Google Scholar
• de Bois MH, Tak PP, Arndt JW, Kluin PM, Pauwels EK, Breedveld FC. Joint scintigraphy for quantification of synovitis with 99mTc-labelled human immunoglobulin G compared to histological examination. Clin Exp Rheumatol. 1995;13(2):155–9.
   PubMed Web of Science ®Google Scholar
• Möttönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis. 1988; 47(8):648–53.
   PubMed Web of Science ®Google Scholar
• Mhlanga JC, Carrino JA, Lodge M, Wang H, Wahl RL. 18F-FDG PET of the hands with a dedicated high-resolution PEM system (arthro-PET): correlation with PET/CT, radiography and clinical parameters. Eur J Nucl Med Mol Imaging. 2014;41(12):2337–45.
   PubMed Web of Science ®Google Scholar
• Naredo E, Collado P, Cruz A, Palop MJ, Cabero F, Richi P, et al. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum. 2007;57(1):116–24.
   PubMed Web of Science ®Google Scholar
• Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58(10):2958–67.
   PubMed Web of Science ®Google Scholar
• Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S, et al. Power doppler but not low-field MRI predict relapse and radiographic disease progression in rheumatoid arthritis patients with low disease activity. Arthritis Rheum. 2012;64(1):67–76.
   PubMed Web of Science ®Google Scholar
• Elzinga EH, van der Laken CJ, Comans EF, Lammertsma AA, Dijkmans BA, Voskuyl AE. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Mol Imaging Biol. 2007;9(6):357–60.
   PubMed Web of Science ®Google Scholar
• Gu JT, Nguyen L, Chaudhari AJ, MacKenzie JD. Molecular characterization of rheumatoid arthritis with magnetic resonance imaging. Top Magn Reson Imaging. 2011;22(2):61–9.
   PubMedGoogle Scholar
• Chaudhari AJ, Bowen SL, Burkett GW, Packard NJ, Godinez F, Joshi AA, et al. High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis. Eur J Nucl Med Mol Imaging. 2010;37(5):1047.
   PubMed Web of Science ®Google Scholar
• Ideguchi H, Ohno S, Hattori H, Senuma A, Ishigatsubo Y. Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs. Arthritis Res Ther. 2006;8(3):R76.
   PubMed Web of Science ®Google Scholar